Reconstitution
Reconstitution is formulation-specific. Do not infer a validated preparation procedure from the existence of glutathione powders marketed for research or supplementation.
BacScience Research Reference
Glutathione Reconstitution & Research Reference
Glutathione is a naturally occurring thiol-containing tripeptide involved in cellular redox regulation, antioxidant defense, detoxification and protection against oxidative stress. This research reference focuses on reduced glutathione (GSH), formulation-dependent reconstitution, concentration calculations, stability, sterile-compounding quality and the current clinical evidence surrounding glutathione.
Class Endogenous thiol tripeptide
Primary form Reduced GSH
Molecular formula C₁₀H₁₇N₃O₆S
Molecular mass ≈307.32 g/mol
Research areas Redox biology, oxidative stress, neurology, dermatology
Human evidence Formulation- and indication-dependent
Regulatory status Route/formulation dependent
Last reviewed September 2026
Glutathione Reconstitution: Quick Answer
Does glutathione require reconstitution? Not necessarily. Glutathione exists in oral, topical and parenteral formulations, and the appropriate preparation method depends on the specific product and intended route.
Is bacteriostatic water an established universal diluent? No. BacScience does not recommend assuming that bacteriostatic water is compatible with every glutathione powder or injectable formulation. The formulation's manufacturer, pharmacy formulation record or authoritative product documentation should establish the appropriate diluent.
Why is this distinction important? Glutathione is chemically sensitive to oxidation, while injectable preparations introduce additional requirements for sterility, endotoxin control, ingredient grade, container closure and validated storage conditions.
What determines concentration? Concentration is determined mathematically by the amount of glutathione present and the final solution volume. Mathematical concentration calculations do not establish that a particular diluent, concentration, route or storage condition is appropriate.
Research Snapshot
The following cards summarize the most important research and quality considerations before examining glutathione concentration or reconstitution questions.
Diluent
Bacteriostatic water is not a universal glutathione diluent. Compatibility must be established from the relevant formulation documentation.
Concentration
Concentration is calculated from mass and final volume. The result is a mathematical conversion, not a validation of chemical or clinical suitability.
Quality
Injectable research material requires appropriate ingredient grade, identity, purity, contaminant controls and route-specific quality documentation.
Clinical Evidence
Human studies exist for oral, topical and intravenous glutathione, but findings cannot automatically be transferred between routes.
Regulatory Status
Regulatory treatment varies by jurisdiction, formulation and route. Compounded injectable glutathione should not be treated as equivalent to an FDA-approved drug product.
Important 2026 injectable-quality warning:
On August 27, 2026, the U.S. FDA reported adverse events following administration of compounded intravenous glutathione and warned compounders not to use dietary-supplement-grade glutathione for injectable preparations. FDA reported that some affected products were associated with elevated endotoxin levels and emphasized that ingredients used for sterile injectable drugs must be appropriate for the intended route of administration.
This is particularly relevant when evaluating glutathione powder, certificates of analysis and any proposed injectable formulation.
What Is Glutathione?
Glutathione is a small endogenous thiol-containing tripeptide composed of glutamate, cysteine and glycine. Its sulfur-containing cysteine residue allows glutathione to participate in redox reactions and antioxidant defense.
The reduced form is commonly abbreviated GSH. When two glutathione molecules become linked through oxidation of their thiol groups, the resulting disulfide is glutathione disulfide (GSSG).
GSH and GSSG therefore represent different chemical states and should not be treated as interchangeable materials in research documentation.
Reduced Glutathione (GSH) vs Oxidized Glutathione (GSSG)
| Characteristic | Reduced Glutathione — GSH | Oxidized Glutathione — GSSG |
|---|---|---|
| Chemical state | Reduced thiol form | Disulfide form |
| Biological role | Major intracellular redox-active glutathione form | Oxidized counterpart generated during redox reactions |
| Interchangeable? | No | No |
| Relevant research measurement | GSH concentration | GSSG concentration and GSH:GSSG ratio |
| Reconstitution assumption | Formulation-specific; chemical state must be verified | |
How Does Glutathione Function Biologically?
Glutathione participates in cellular redox homeostasis and can act as a reducing agent in biochemical reactions. It also participates in glutathione-dependent enzyme systems, including glutathione peroxidases and glutathione transferases.
The GSH/GSSG system is frequently used as an indicator of cellular redox state. Maintaining appropriate intracellular glutathione balance is particularly relevant to oxidative-stress research.
Importantly, a biochemical role does not automatically demonstrate a clinical benefit from administration of supplemental or injectable glutathione.
What Is Glutathione Being Studied For?
Redox & Oxidative Stress
Glutathione is extensively investigated as part of cellular antioxidant and redox systems. Research includes oxidative stress, mitochondrial function, inflammatory signaling and cellular defense.
Neurological Research
Clinical studies have investigated glutathione in neurological conditions, including Parkinson's disease. Evidence remains investigational and route-specific.
Dermatology
Oral and topical glutathione have been studied for pigmentation and skin-related outcomes. Systematic reviews describe evidence as limited or inconsistent.
Clinical & Translational Research
Research has examined glutathione in several areas including oxidative stress, chemotherapy-related toxicity, metabolic health, inflammatory conditions and other translational applications.
Human Clinical Research
Human research on glutathione spans multiple formulations and routes. Results from one route should not be used as evidence that another route has the same pharmacokinetics, efficacy or safety profile.
| Route / Form | Research Area | Evidence Interpretation |
|---|---|---|
| Oral GSH | Systemic glutathione status | Human trials demonstrate that oral supplementation can affect glutathione-related biomarkers. |
| Topical GSH | Dermatology / pigmentation | Some clinical studies report changes in pigmentation, but the evidence base remains limited. |
| IV GSH | Neurological and other clinical research | Investigational evidence exists, but safety and efficacy depend on indication and formulation. |
Route-specific evidence matters.
A clinical study involving oral glutathione does not establish the efficacy or safety of injectable glutathione. Likewise, an IV research protocol does not establish the suitability of a particular commercial powder or diluent.
Doses Studied in Clinical Research
Published clinical studies have evaluated different amounts depending on the route, formulation and research question. These research doses should not be interpreted as recommended dosing instructions.
| Research Route | Example Published Research | Important Limitation |
|---|---|---|
| Oral | 250–1,000 mg/day in a 6-month randomized controlled trial | Investigated effects on body glutathione stores in healthy adults. |
| Oral | 500 mg/day in a 4-week randomized trial | Studied skin pigmentation outcomes; not a general therapeutic dosing recommendation. |
| IV | 1,400 mg three times weekly for 4 weeks in a Parkinson's pilot | Small pilot study; no significant difference in primary clinical outcomes was established. |
For example, the Parkinson's disease pilot randomized 21 participants and evaluated IV glutathione at 1,400 mg three times weekly for four weeks. The treatment was reported as tolerated, but the study was small and did not establish significant efficacy. :contentReference[oaicite:3]{index=3}
A separate six-month randomized controlled trial found that oral glutathione at 250 or 1,000 mg/day increased glutathione measures in several blood and cellular compartments in healthy adults. :contentReference[oaicite:4]{index=4}
Glutathione Reconstitution Research
There is no universal glutathione reconstitution recipe.
Glutathione preparations differ in chemical form, grade, formulation, intended route, excipients, container closure, concentration and validated storage conditions.
Therefore, a researcher should not assume that every glutathione vial should be reconstituted with bacteriostatic water.
The correct diluent, if reconstitution is required, should come from the applicable product documentation, validated formulation record, manufacturer instructions or qualified sterile-compounding procedure.
What Must Be Verified?
- Reduced versus oxidized glutathione form
- Intended route of administration
- Material grade and intended use
- Specified diluent, if any
- Target or labeled concentration
- pH and formulation requirements
- Container and closure system
- Validated storage conditions
- Beyond-use or expiration information
- Sterility and endotoxin controls
What Should Not Be Assumed?
- BAC water is automatically compatible
- Supplement-grade powder is suitable for injection
- A COA alone proves sterility
- High purity automatically means low endotoxin
- Oral research dosing transfers to IV use
- One formulation's stability data applies to another
- Appearance alone confirms chemical stability
Glutathione Diluent Considerations
The diluent question is particularly important for glutathione because compatibility involves more than simple solubility.
| Diluent Question | BacScience Research Position |
|---|---|
| Is bacteriostatic water universally established? | No |
| Can sterile water be appropriate? | Potentially, depending on the documented formulation. |
| Can normal saline be relevant? | Yes, certain IV compatibility studies use 0.9% sodium chloride, but this does not establish a universal powder-reconstitution protocol. |
| Does diluent selection prove stability? | No |
| Should the product documentation control? | Yes |
Published laboratory compatibility research has evaluated reduced glutathione with numerous IV drugs using 0.9% sodium chloride and 5% dextrose in simulated Y-site conditions. This is useful compatibility evidence, but it should not be misrepresented as a universal reconstitution instruction for every glutathione product. :contentReference[oaicite:5]{index=5}
Glutathione Concentration Calculator
Concentration is a mathematical relationship between the quantity of compound and the final solution volume.
Concentration (mg/mL) = Total glutathione (mg) ÷ Final volume (mL)
Example for mathematical reference only: if a hypothetical solution contains 1,000 mg of glutathione in a final volume of 10 mL, the mathematical concentration is 100 mg/mL.
This calculation does not determine whether that concentration is chemically stable, sterile, clinically appropriate, compatible with a specific diluent, or suitable for injection.
Open Universal BAC Water Calculator
Important calculator limitation
The BacScience calculator performs mathematical concentration and volume conversions. It does not establish chemical compatibility, sterility, endotoxin safety, stability, route suitability or a medically appropriate diluent.
Glutathione Stability & Storage Research
Reduced glutathione contains a reactive sulfhydryl group and can undergo oxidation to GSSG. Consequently, stability should be considered in terms of chemical integrity as well as microbial quality.
Chemical Stability
- Oxidation can convert GSH toward GSSG.
- Light, oxygen, temperature and formulation conditions may influence stability.
- A clear solution does not necessarily prove chemical integrity.
- Validated stability data should be formulation-specific.
Storage Interpretation
- Follow the specific manufacturer's or compounding pharmacy's validated storage instructions.
- Do not transfer stability claims from one glutathione formulation to another.
- Reconstituted material may have a different stability profile from the original dry material.
- Beyond-use dating requires appropriate supporting data and applicable sterile-compounding standards.
Sterility & Endotoxin Considerations
Sterility and endotoxin control are separate quality attributes. A material can appear chemically pure while still being unsuitable for sterile administration.
Glutathione injectable quality requires special attention.
FDA's August 2026 safety communication reported at least 30 patients with adverse events following IV glutathione prepared by different compounding pharmacies. FDA reported that the glutathione used in the affected products was labeled dietary-supplement grade and that some pharmacies recalled products because of elevated endotoxin levels.
FDA specifically emphasized that dietary-supplement-grade ingredients should not be used to make injectable drugs and that quality must be built into the sourcing and manufacturing process rather than relying on testing alone. :contentReference[oaicite:6]{index=6}
FDA previously documented a 2019 glutathione compounding incident in which patients experienced systemic reactions and FDA testing found excessive bacterial endotoxin in implicated L-glutathione material. :contentReference[oaicite:7]{index=7}
USP General Chapter <797> describes standards for compounded sterile preparations and addresses risks including microbial contamination, excessive bacterial endotoxins, incorrect strength and inappropriate ingredient quality. :contentReference[oaicite:8]{index=8}
Quality & Purity Considerations
For research involving glutathione, the certificate of analysis should be evaluated as one component of a broader quality assessment.
Identity
Confirm that the material is actually the intended glutathione form and distinguish GSH from GSSG.
Assay / Purity
Evaluate the reported assay and impurity profile using an appropriate analytical method.
Material Grade
Determine whether the material is intended for research, pharmaceutical or dietary use. These categories should not be treated as equivalent.
Endotoxin
Injectable applications require appropriate endotoxin controls. Dietary-grade purity does not establish injectable endotoxin safety.
Sterility
Sterility claims must be supported by appropriate manufacturing and testing processes.
Traceability
Batch/lot number, manufacturer, source and analytical documentation should remain traceable throughout the research workflow.
Regulatory Status
Glutathione should not be described as having one universal regulatory status because its legal and regulatory treatment varies according to jurisdiction, dosage form, intended use and route.
In the United States, compounded glutathione preparations are subject to applicable federal and state requirements. FDA has specifically raised concerns about the use of inappropriate glutathione ingredients in sterile injectable compounding and continues to monitor related quality risks.
Researchers should distinguish between a dietary supplement, a research material, a compounded preparation and an approved pharmaceutical product.
Safety Findings
Safety findings depend strongly on formulation, route, dose, duration and patient population.
- Oral clinical studies have generally reported relatively good short- to medium-term tolerability in the studied populations.
- IV glutathione has been studied in small clinical trials, but the evidence base is substantially narrower than the popularity of IV glutathione might suggest.
- Injectable quality introduces risks that do not apply in the same way to oral dietary supplements, including sterility and bacterial endotoxin exposure.
- Recent FDA reports demonstrate that inappropriate ingredient grade and endotoxin contamination can create serious risks with compounded injectable glutathione.
Glutathione & Skin-Lightening Research
Glutathione has been studied in dermatology, particularly for pigmentation and skin-lightening outcomes.
A 2019 systematic review found limited and inconsistent clinical evidence and concluded that the evidence for oral glutathione's effects on skin color remained inconclusive. :contentReference[oaicite:9]{index=9}
More recent reviews continue to distinguish oral, topical and IV approaches. A 2024 systematic review reported that evidence for IV glutathione in skin-lightening was particularly problematic because of limited efficacy evidence and safety concerns. :contentReference[oaicite:10]{index=10}
These findings should not be used to infer that injectable glutathione is an established cosmetic treatment.
Research Limitations
- Many human studies involve relatively small participant groups.
- Formulations and routes vary substantially between studies.
- Oral evidence cannot automatically be transferred to injectable glutathione.
- Short-term safety findings cannot establish long-term safety.
- Commercially available glutathione materials can differ in grade, purity, formulation and manufacturing controls.
- Research doses should not be interpreted as clinical prescribing recommendations.
Frequently Asked Questions
What is glutathione?
Glutathione is an endogenous thiol-containing tripeptide composed of glutamate, cysteine and glycine. It is central to cellular redox regulation and antioxidant defense.
What is reduced glutathione?
Reduced glutathione, abbreviated GSH, is the thiol-containing reduced form of glutathione and is distinct from oxidized glutathione (GSSG).
Is GSH the same as GSSG?
No. GSH is reduced glutathione, whereas GSSG is glutathione disulfide, the oxidized form produced when two glutathione molecules participate in disulfide formation.
Can glutathione be reconstituted with BAC water?
Bacteriostatic water should not be assumed to be a universal glutathione diluent. Compatibility must be established for the exact formulation and intended route.
How do you calculate glutathione concentration?
For mathematical purposes, concentration in mg/mL equals total glutathione in mg divided by the final solution volume in mL. This calculation does not establish formulation or clinical suitability.
Does the BacScience BAC Water Calculator tell me which diluent to use?
No. The calculator performs mathematical concentration conversions. It does not establish chemical compatibility, sterility, endotoxin safety, stability or clinical appropriateness.
Why is endotoxin important for injectable glutathione?
Bacterial endotoxins can produce serious systemic reactions when present at inappropriate levels in injectable preparations. FDA has specifically reported endotoxin-related concerns involving compounded glutathione.
Can supplement-grade glutathione be used to make an injectable?
It should not be assumed to be appropriate. FDA's August 2026 communication specifically warned compounders not to use dietary-supplement-grade glutathione for injectable drugs.
Is IV glutathione proven for skin lightening?
No. Evidence for IV glutathione in cosmetic skin lightening is limited and safety concerns have been reported. It should not be presented as an established evidence-based cosmetic treatment.
Does oral glutathione research prove that injectable glutathione works?
No. Different routes can have different pharmacokinetics, bioavailability, formulation requirements and safety profiles.
Calculate Concentration — Without Assuming Compatibility
Use the BacScience Universal BAC Water Calculator for mathematical concentration and volume conversions. Always verify the actual diluent, formulation and storage requirements from authoritative product documentation before preparing a research solution.
Open BAC Water CalculatorScientific References
- U.S. Food & Drug Administration. FDA reminds compounders not to use dietary supplement grade glutathione for injectables. August 27, 2026.
- U.S. Food & Drug Administration. FDA highlights concerns with using dietary ingredient glutathione to compound sterile injectables. June 7, 2019.
- U.S. Pharmacopeia. General Chapter <797> Pharmaceutical Compounding — Sterile Preparations.
- Hauser RA, Lyons KE, McClain T, et al. Randomized, double-blind, pilot evaluation of intravenous glutathione in Parkinson's disease. Movement Disorders. 2009.
- Richie JP Jr, et al. Randomized controlled trial of oral glutathione supplementation on body stores of glutathione. European Journal of Nutrition. 2014.
- Dilokthornsakul W, Dhippayom T, Dilokthornsakul P. The clinical effect of glutathione on skin color and other related skin conditions: systematic review. Journal of Cosmetic Dermatology. 2019.
- Recent clinical and translational literature continues to investigate glutathione bioavailability, redox biology and formulation-dependent therapeutic applications.
Last Reviewed
September 11, 2026
This page should be reviewed periodically as regulatory communications, clinical research, formulation data and sterile-compounding safety information evolve.
Research information only. This page is provided for scientific and educational reference and is not medical advice, prescribing guidance, or a substitute for a validated pharmaceutical formulation. Glutathione products differ in chemical form, grade, formulation, route and quality controls. Do not use the mathematical examples on this page as instructions for human administration. For injectable preparations, qualified healthcare professionals and applicable sterile-compounding requirements should determine formulation, preparation, storage and administration.